Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-1.0%
5Y CAGR-3.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-1.0%/yr
Quarterly compound
5Y CAGR
-3.1%/yr
Consistent
Percentile
P74
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 18.83% |
| Q3 2025 | 14.67% |
| Q2 2025 | 10.00% |
| Q1 2025 | -27.87% |
| Q4 2024 | 11.60% |
| Q3 2024 | 10.47% |
| Q2 2024 | 3.92% |
| Q1 2024 | -22.96% |
| Q4 2023 | 21.32% |
| Q3 2023 | -3.41% |
| Q2 2023 | 33.99% |
| Q1 2023 | -23.27% |
| Q4 2022 | 19.42% |
| Q3 2022 | 0.79% |
| Q2 2022 | 14.53% |
| Q1 2022 | -9.85% |
| Q4 2021 | 13.14% |
| Q3 2021 | 13.05% |
| Q2 2021 | 25.28% |
| Q1 2021 | -20.73% |
| Q4 2020 | 22.01% |
| Q3 2020 | 31.15% |
| Q2 2020 | 6.38% |
| Q1 2020 | 0.00% |